Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies
- 1 October 1993
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 265 (4), E572-E577
- https://doi.org/10.1152/ajpendo.1993.265.4.e572
Abstract
Throughout gestation, maternal insulin-like growth factor I (IGF-I) increases progressively despite suppressed pituitary growth hormone (GH) secretion. We have previously shown that in normal pregnancy, a specific placental GH variant, rather than human placental lactogen (hPL), substitutes for pituitary GH in the regulation of maternal IGF-I. We studied the maternal IGF-I secretion in a cohort of 286 normal and abnormal pregnancies (617 blood samples). Regardless of pathology and gestational age, IGF-I values correlated with corresponding placental GH but not with hPL values. Similar correlations were evidenced for each 2-wk gestational period between 32 and 39 wk. In pathological pregnancies, when only those hormonal results that are obtained before any treatment are considered and diabetes is excluded, IGF-I levels were closely related to corresponding placental GH, but not to hPL. In women with a fetoplacental unit disorder, low placental GH levels resulted in low IGF-I and in a secondary pituitary GH increase, whereas in patients without detectable impairment of the fetoplacental unit normal placental GH corresponded to normal IGF-I. These results suggest that in pathological as well as in normal pregnancy, placental GH, and not hPL, substitutes for pituitary GH to regulate the maternal IGF-I secretion.Keywords
This publication has 21 references indexed in Scilit:
- Insulin-Like Growth Factor Measurements in the Evaluation of Growth Hormone SecretionHormone Research, 1990
- Growth hormone 24‐h serum profiles during pregnancy—lack of pulsatility for the secretion of the placental variantBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitusJournal of Endocrinological Investigation, 1988
- The Physiology of Growth Hormones (GHs) in Pregnant Women and Partial Characterization of the Placental GH Variant*Journal of Clinical Endocrinology & Metabolism, 1988
- EXPRESSION OF THE GROWTH HORMONE VARIANT GENE IN HUMAN PLACENTAJournal of Clinical Endocrinology & Metabolism, 1987
- Insulin-like growth factors (IGF) I and II in diabetic pregnancy: Suppression of normal pregnancy-induced rise of IGF-IDiabetologia, 1986
- Effect of Diabetes and its Control on Insulin-like Growth Factors in the Young Subject with Type I DiabetesDiabetes, 1984
- Immunoassay of a Somatomedin-Binding Protein from Human Amniotic Fluid: Levels in Fetal, Neonatal, and Adult Sera*Journal of Clinical Endocrinology & Metabolism, 1984
- Serum Immunoreactive Somatomedin Levels in Normal Adults, Pregnant Women at Term, Children at Various Ages, and Children with Constitutionally Delayed Growth*Journal of Clinical Endocrinology & Metabolism, 1981
- SERUM IMMUNOREACTIVE SOMATOMEDIN-C IS ELEVATED LATE IN PREGNANCY1Journal of Clinical Endocrinology & Metabolism, 1978